Gland Pharma Ltd. (GLAND): Gland Pharma Share Price Rises 2.33% Today to Rs 2,895

Published: 17 September 2026 at 11:18:44 AM IST

Gland Pharma Share Price moved to Rs 2,895 today, up 2.33% from the previous close of Rs 2,829.2, with market capitalisation at Rs 47,530.55 crore. The stock opened at Rs 2,817.55, hit an intraday low of Rs 2,817.55 and a high of Rs 2,899. The move places Gland Pharma Share Price Today in focus for traders and long-term investors tracking the latest stock news on Univest.

The verified data confirms a same-day price rise, but it does not establish a company-specific catalyst. Even so, the move is notable because it comes with turnover of Rs 29.59 crore and valuation metrics that remain important for context. Gland Pharma Stock News today is therefore best read as a price event first, followed by a review of fundamentals, sector comparison and peer positioning. Univest tracks these developments so readers can place the move within a broader market frame without guessing the reason behind it.

Gland Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,895
Previous Close	Rs 2,829.2
Today's Move	Rs 65.8 (+2.33%)
Open	Rs 2,817.55
High	Rs 2,899
Low	Rs 2,817.55
Turnover	Rs 29.59 crore
Market Capitalisation	Rs 47,530.55 crore
Market Cap Category	Large Cap

Gland Pharma Ltd. (GLAND) rose to Rs 2,895 from the previous close of Rs 2,829.2, a move of Rs 65.8 or 2.33%. The stock opened at Rs 2,817.55, reached a high of Rs 2,899, recorded a low of Rs 2,817.55.

Gland Pharma Share Price Today closed higher by Rs 65.8, or 2.33%, at Rs 2,895. The stock traded between Rs 2,817.55 and Rs 2,899 during the session, which shows that the day’s gain was built inside a fairly contained range. Compared with the previous close of Rs 2,829.2, the finish was stronger and left Gland Pharma among the Stocks Rising Today in the Indian Stock Market.

For readers following Gland Pharma Share Price Live updates, the most relevant facts are the day’s open, low, high, close and turnover. This is a price rise event, not a claimed catalyst-led move. Univest records the event as an observed market outcome and keeps the interpretation tied to verified numbers only.

Gland Pharma Ltd. (GLAND) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 47,530.55 crore
P/E Ratio	41.36x
P/B Ratio	4.39x
ROE	10.56%
ROCE	14.96%
EPS	Rs 68.41
Book Value Per Share	Rs 644.16
Dividend Yield	0.71%

Gland Pharma Ltd. (GLAND) fundamental metrics show P/E 41.36x, P/B 4.39x, ROE 10.56%, ROCE 14.96%. These figures provide context only and are not a buy or sell signal.

Gland Pharma Ltd. has a market capitalisation of Rs 47530.55 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 41.36x, P/B at 4.39x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.56% and ROCE of 14.96%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 68.41, book value per share of Rs 644.16, dividend yield of 0.71%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	41.36x
Benchmark Median P/E	31.35x
Benchmark Average P/E	47.81x
Benchmark P/E Range	3.45x to 661.74x
Company P/B Ratio	4.39x
Benchmark Median P/B	2.98x
Company ROE	10.56%
Benchmark Median ROE	11.78%
Company ROCE	14.96%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 47,530.55 crore
Benchmark Median Market Cap	Rs 735.67 crore

Gland Pharma Ltd. (GLAND) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Gland Pharma Ltd. (GLAND) has a P/E ratio of 41.36x, which is above the benchmark median of 31.35x, a difference of +31.93%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Gland Pharma Ltd. (GLAND) has a ROE of 10.56%, which is below the benchmark median of 11.78%, a difference of -10.36%. Gland Pharma Ltd. (GLAND) has a ROCE of 14.96%, which is above the benchmark median of 13.65%, a difference of +9.6%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,40,277.97	36.77	5.14	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,43,965.63	83.5	13.83	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.11	20.44	26.76	19.27
Cipla Ltd.	CIPLA	1,09,949.53	32.59	3.12	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,09,625.67	24.42	4.09	19.69	21.39

Gland Pharma Ltd. (GLAND) has a P/E ratio of 41.36x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.56% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 14.96% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Gland Pharma Ltd. (GLAND) has a market capitalisation of Rs 47,530.55 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Gland Pharma

• Gland Pharma Share Price rose 2.33% today to Rs 2,895, after closing above the previous close of Rs 2,829.2.
• The session’s range was Rs 2,817.55 to Rs 2,899, and turnover was Rs 29.59 crore.
• Market capitalisation stands at Rs 47,530.55 crore, giving the move a sizeable market-cap backdrop.
• P/E is 41.36, P/B is 4.39, ROE is 10.56 and ROCE is 14.96, all of which shape the stock’s valuation context.
• Against the same-industry benchmark, the company’s P/E is above the median and its ROCE is above the median, which supports closer stock news tracking on Univest.

About Gland Pharma

Gland Pharma Ltd. is part of the Pharmaceuticals & Drugs industry in the Healthcare sector. The company’s market capitalisation and valuation profile show that it is already a significant listed name in the Indian market, and its share price is often assessed through earnings, profitability and industry positioning. Gland Pharma Share Price is therefore not just a daily market figure; it is also a reflection of how the market is valuing the company’s earnings base and capital employed.

The supplied data does not break down product lines or revenue mix, so the most accurate company overview is the one anchored in the available financial and sector numbers. On that basis, Gland Pharma Stock News today is relevant because it combines a same-day price rise with a valuation profile that can be compared against a large Pharmaceuticals & Drugs benchmark set on Univest.

Track Gland Pharma Share Price on Univest

Use Gland Pharma Ltd. (GLAND) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track Gland Pharma Share Price on Univest for live updates, financial ratios, shareholding pattern, market capitalisation, 52-week levels and broader market insights. Univest also helps readers follow Gland Pharma Share Price Today alongside sector and peer context, so the move can be read as part of a wider stock analysis flow.

For investors scanning Gland Pharma Latest News, Univest keeps the company page focused on verified data and practical market context. That makes it easier to review Gland Pharma Share Price Update stories, compare sector benchmarks and revisit the stock when new market information appears.

Frequently Asked Questions

Why did Gland Pharma Share Price rise today?

Ans. Gland Pharma Share Price rose 2.33% today to Rs 2,895. The supplied data confirms the price event, but it does not establish a company-specific catalyst behind the move. The previous close was Rs 2,829.2.

What is Gland Pharma Share Price today?

Ans. Gland Pharma Share Price today is Rs 2,895. It finished Rs 65.8 above the previous close of Rs 2,829.2, making it a notable same-day share price rise. The previous close was Rs 2,829.2.

What is Gland Pharma market capitalisation?

Ans. Gland Pharma’s market capitalisation is Rs 47,530.55 crore. That is far above the same-industry median of Rs 735.67 crore and reflects a much larger market-cap scale. The company operates in the Healthcare sector.

What is Gland Pharma P/E ratio?

Ans. Gland Pharma’s P/E ratio is 41.36. It stands above the same-industry median of 31.35 and below the same-industry average of 47.81, based on 169 companies. The company trades at a P/E ratio of 41.36x.

How do Gland Pharma fundamentals compare with peers?

Ans. Gland Pharma’s P/E is higher than Cipla and Zydus Lifesciences, while ROE at 10.56 is below several peers. Its ROCE of 14.96 is also below stronger operating-return names. Comparable listed companies include Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd., Torrent.

What is Gland Pharma dividend yield?

Ans. Gland Pharma dividend yield is 0.71%. This is historical current data and should be read with the stock’s valuation, profitability and sector context rather than as a future payout guide.

How does Gland Pharma compare with the Healthcare sector?

Ans. Gland Pharma belongs to Healthcare and the Pharmaceuticals & Drugs industry. Its P/E is above the industry median, while ROCE is above both the industry median and average across the benchmark set.